<DOC>
	<DOCNO>NCT00492336</DOCNO>
	<brief_summary>This study new medication treatment cognitive impairment ( think difficulty ) negative symptom people schizophrenia . The new medication rasagiline . Rasagiline drug approve Food Drug Administration treatment Parkinson 's disease . It use treat cognitive problem .</brief_summary>
	<brief_title>Rasagiline Treatment Persistent Negative Symptoms Schizophrenia</brief_title>
	<detailed_description>The study consist two phase : 4-week continued stability phase ( lead-in phase ) 12-week double-blind treatment phase . In lead-in phase , subject receive antipsychotic medication , manifest moderate severe persistent negative symptom , remain maintenance regimen least four week . The treatment phase 12-week , parallel group , double-blind , placebo-controlled trial adjunctive rasagiline ( 1 mg/day ) , selective MAO-B oxidase inhibitor .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>Subjects meet DSMIV criterion schizophrenia schizoaffective disorder . Current treatment one second generation antipsychotic , except ziprasidone On second generation antipsychotic ( ) least 56 day On dose second generation antipsychotic ( ) least 30 day 22item SANS : Total score ( i.e.all item minus global item poverty content speech ) great 20 global Rating Affective Flattening great equal 3 global Rating alogia great equal 3 BPRS : Sum four positive symptom item less equal 16 ( item 4,11,12,15 ) BPRS : Sum four Anxiety/Depression Factor item less equal 14 ( item 1,2,5,9 ) SimpsonAngus Scale : Total score less equal 8 DSMIV Major Depressive Disorder within last 6 month Current treatment ziprasidone DSMIV diagnosis alcohol substance dependence within last 6 month DSMIV criterion alcohol substance abuse within last month evidence illicit substance use , identify urine toxicology screen History organic brain disorder , mental retardation , epilepsy , medical condition , whose pathology treatment could alter presentation treatment schizophrenia significantly increase risk associate propose treatment protocol . See listed Uncontrolled hypertension define BP exceed 145/90 3 consecutive reading despite adequate treatment , pheochromocytoma , melanoma , hepatic insufficiency Pregnancy lactation female Pheochromocytoma Melanoma Hepatic insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Cognitive impairment</keyword>
	<keyword>Negative symptom</keyword>
</DOC>